Home Akome Biotech

Akome Biotech

acquired
-
Developer of Therapeutics for Neurological Disorders
Basic
Enterprise Profile

Basic Information

Akome Biotech provides effective and safe solutions for patients suffering from stroke and neurological disorders. The goal is to develop psychedelic-based drugs to help patients overcome specific diseases. The targeted therapies of these drugs are for the treatment of Cluster Headache (CH), Alzheimer's Disease (AD), and depression.
Akome Biotech Ltd.
United States of America
unclear
--
--

Enterprise Profile

Industrial Sector
New Drug Development Manufacture of Chemical Drug Active Pharmaceutical Ingredients
Concept
Depression
Application Scenarios
Chemical Drug